Peptilogics

About Peptilogics

Peptilogics aims to revolutionize the discovery of novel peptide therapeutics for patients with serious and life-threatening diseases by combining peptide biology with machine learning. Their approach focuses on drug design at a massive scale to create next-generation medicines through precision engineering.

Products & Services

AI Platform:An AI-driven platform designed to transform peptide drug discovery by using advanced algorithms, supercomputing, and peptide R&D for in silico predictive design across diverse targets.

Pipeline (Lead Program: PLG0206):A pipeline of peptide therapeutics targeting serious conditions with high unmet medical needs, with PLG0206 as the lead program.

Specialties

Peptide Therapeutics AI-Driven Drug Discovery Machine Learning in Drug Design Precision Engineering of Medicines

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B2 T: - FT: Series B2	A: 78000000 MR: - FA: 78 million FAN: 78000000	D: 2025-10-16 FD: 2025-10-16	6 investors

Series B2 Latest

2025-10-16

$78.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Nick Pachuda

Chief Operating Officer of Portfolio & Development

N

Nicholas Nystrom

Chief Technology Officer

N

Nicholas A. Nystrom

Chief Technology Officer

A

Albert Fonticiella

VP of People

J

Jonathan Steckbeck

CEO & Founder

D

Dietrich Stephan

Chairman

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Peptilogics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised